Compare THRX to:
After Hours:
13.3465
0.22 (1.65%) 4:24pm ET
| Last Trade: | 13.13 |
|---|---|
| Trade Time: | Nov 25 |
| Change: | |
| Prev Close: | 13.40 |
| Open: | 13.81 |
| Bid: | 12.62 x 100 |
| Ask: | 13.88 x 100 |
| 1y Target Est: | 18.63 |
| Day's Range: | 13.10 - 13.54 |
|---|---|
| 52wk Range: | 6.01 - 18.56 |
| Volume: | 237,305 |
| Avg Vol (3m): | 329,302 |
| Market Cap: | 834.57M |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.26 |
| Div & Yield: | N/A (N/A) |
| Fri, Nov 13 | Unique Strategy Generates Big Returns for BaupostIndie Research |
| Tue, Nov 10 | THERAVANCE INC FinancialsEDGAR Online Financials |
| Thu, Nov 5 | Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United StatesMarketwire |
| Wed, Nov 4 | THERAVANCE INC Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Tue, Nov 3 | Theravance to Present at the 18th Annual Credit Suisse Health Care ConferenceMarketwire |
| Mon, Nov 2 | Theravance Announces New Employment Inducement AwardMarketwire |
| Wed, Oct 28 | Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia and Complicated Skin and Soft Tissue Infections in EuropeMarketwire |
| Tue, Oct 27 | Theravance, Inc. Q3 2009 Earnings Call Transcriptat Seeking Alpha |
| Tue, Oct 27 | Theravance Third Quarter 2009 Financial Results Call scheduled for 5:00 pm ET todayShareholder.com |
| Tue, Oct 27 | THERAVANCE INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.